Surge in number of AF patients being anticoagulated

RAPID take-up of direct-acting oral anticoagulants (DOACs) in Australia has led to more patients at high stroke risk receiving preventive therapy, a study shows.

Although warfarin was the most commonly prescribed anticoagulant in patients with atrial fibrillation (AF) in 2013 and 2014, DOAC scripts leapt 10-fold in the same period.

National PBS data shows DOACs increased from 4% to 29% as a proportion of oral anticoagulants prescribed per year, whereas warfarin usage decreased marginally from 38.4% in 2013 to 34.4% the following year.

With no major drop in warfarin